Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

A Web-Based Decision Tool to Improve Contraceptive Counseling for Women With Chronic Medical Conditions: Protocol For a Mixed Methods Implementation Study.

Wu JP, Damschroder LJ, Fetters MD, Zikmund-Fisher BJ, Crabtree BF, Hudson SV, Ruffin MT IV, Fucinari J, Kang M, Taichman LS, Creswell JW.

JMIR Res Protoc. 2018 Apr 18;7(4):e107. doi: 10.2196/resprot.9249.

2.

Spatial Variation of the Native Colon Microbiota in Healthy Adults.

Flynn KJ, Ruffin MT 4th, Turgeon DK, Schloss PD.

Cancer Prev Res (Phila). 2018 Jul;11(7):393-402. doi: 10.1158/1940-6207.CAPR-17-0370. Epub 2018 Apr 10.

PMID:
29636352
3.

Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations.

Djuric Z, Bassis CM, Plegue MA, Ren J, Chan R, Sidahmed E, Turgeon DK, Ruffin MT 4th, Kato I, Sen A.

J Acad Nutr Diet. 2018 Apr;118(4):606-616.e3. doi: 10.1016/j.jand.2017.09.013. Epub 2017 Dec 21.

PMID:
29274690
4.

Normalization of the microbiota in patients after treatment for colonic lesions.

Sze MA, Baxter NT, Ruffin MT 4th, Rogers MAM, Schloss PD.

Microbiome. 2017 Nov 16;5(1):150. doi: 10.1186/s40168-017-0366-3.

5.

The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity.

Djuric Z, Turgeon DK, Sen A, Ren J, Herman K, Ramaswamy D, Zhao L, Ruffin MT 4th, Normolle DP, Smith WL, Brenner DE.

Cancer Prev Res (Phila). 2017 Dec;10(12):729-737. doi: 10.1158/1940-6207.CAPR-17-0091. Epub 2017 Nov 13.

PMID:
29133307
6.

Correlates of Risky Alcohol Use Among Women from Appalachian Ohio.

Tzilos GK, Hade EM, Ruffin MT, Paskett ED.

Rural Ment Health. 2017;41(2):152-161. doi: 10.1037/rmh0000067. Epub 2017 Jun 8.

7.

The Effect of Perceived Stress on Epstein-Barr Virus Antibody Titers in Appalachian Ohio Women.

Brook MJ, Christian LM, Hade EM, Ruffin MT.

Neuroimmunomodulation. 2017;24(2):67-73. doi: 10.1159/000478658. Epub 2017 Sep 22.

PMID:
28934729
8.

Correlates of Patient Intent and Preference on Colorectal Cancer Screening.

Jimbo M, Sen A, Plegue MA, Hawley ST, Kelly-Blake K, Rapai M, Zhang M, Zhang Y, Ruffin MT 4th.

Am J Prev Med. 2017 Apr;52(4):443-450. doi: 10.1016/j.amepre.2016.11.026. Epub 2017 Feb 3.

PMID:
28169019
9.

Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff.

Presser BE, Katz ML, Shoben AB, Moore D, Ruffin MT, Paskett ED, Reiter PL.

J Cancer Educ. 2017 Jan 10. doi: 10.1007/s13187-017-1164-0. [Epub ahead of print]

10.

Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results.

Roberts JS, Gornick MC, Carere DA, Uhlmann WR, Ruffin MT, Green RC.

Public Health Genomics. 2017;20(1):36-45. doi: 10.1159/000455006. Epub 2017 Jan 10.

11.

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.

Gray SW, Gollust SE, Carere DA, Chen CA, Cronin A, Kalia SS, Rana HQ, Ruffin MT 4th, Wang C, Roberts JS, Green RC.

J Clin Oncol. 2017 Feb 20;35(6):636-644. doi: 10.1200/JCO.2016.67.1503. Epub 2016 Dec 12.

12.

DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.

Baxter NT, Koumpouras CC, Rogers MA, Ruffin MT 4th, Schloss PD.

Microbiome. 2016 Nov 14;4(1):59.

13.

Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue.

Sidahmed E, Sen A, Ren J, Patel A, Turgeon DK, Ruffin MT, Brenner DE, Djuric Z.

Nutr Cancer. 2016 Oct;68(7):1192-201. doi: 10.1080/01635581.2016.1213866. Epub 2016 Aug 22.

14.

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.

Baxter NT, Ruffin MT 4th, Rogers MA, Schloss PD.

Genome Med. 2016 Apr 6;8(1):37. doi: 10.1186/s13073-016-0290-3.

15.

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.

van der Wouden CH, Carere DA, Maitland-van der Zee AH, Ruffin MT 4th, Roberts JS, Green RC; Impact of Personal Genomics Study Group.

Ann Intern Med. 2016 Apr 19;164(8):513-22. doi: 10.7326/M15-0995. Epub 2016 Mar 1.

PMID:
26928821
16.

No evidence in US of HPV16/18 cancer precursor reduction.

Pendleton ME, Ruffin MT 4th, Harper DM.

Vaccine. 2016 Jan 4;34(2):200. doi: 10.1016/j.vaccine.2015.07.047. Epub 2015 Jul 29. No abstract available.

PMID:
26232544
17.

How Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics Study.

Ostergren JE, Gornick MC, Carere DA, Kalia SS, Uhlmann WR, Ruffin MT, Mountain JL, Green RC, Roberts JS; PGen Study Group.

Public Health Genomics. 2015;18(4):216-24. doi: 10.1159/000431250. Epub 2015 Jun 16.

18.

Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?

Zazove P, Plegue MA, Uhlmann WR, Ruffin MT 4th.

J Am Board Fam Med. 2015 May-Jun;28(3):334-42. doi: 10.3122/jabfm.2015.03.140149.

19.

Impact of an Electronic Health Record (EHR) Reminder on Human Papillomavirus (HPV) Vaccine Initiation and Timely Completion.

Ruffin MT 4th, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW.

J Am Board Fam Med. 2015 May-Jun;28(3):324-33. doi: 10.3122/jabfm.2015.03.140082.

20.

Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.

Umoh FI, Kato I, Ren J, Wachowiak PL, Ruffin MT 4th, Turgeon DK, Sen A, Brenner DE, Djuric Z.

Eur J Nutr. 2016 Mar;55(2):793-798. doi: 10.1007/s00394-015-0900-7. Epub 2015 Apr 24.

21.

Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr).

Wang C, Sen A, Plegue M, Ruffin MT 4th, O'Neill SM, Rubinstein WS, Acheson LS; Family Healthware™ Impact Trial (FHITr) Group; Family Healthware Impact Trial FHITr Group.

Prev Med. 2015 Aug;77:28-34. doi: 10.1016/j.ypmed.2015.04.007. Epub 2015 Apr 19.

22.

Effects of a Mediterranean Diet Intervention on Anti- and Pro-Inflammatory Eicosanoids, Epithelial Proliferation, and Nuclear Morphology in Biopsies of Normal Colon Tissue.

Djuric Z, Turgeon DK, Ren J, Neilson A, Plegue M, Waters IG, Chan A, Askew LM, Ruffin MT 4th, Sen A, Brenner DE.

Nutr Cancer. 2015;67(5):721-9. doi: 10.1080/01635581.2015.1029637. Epub 2015 Apr 14.

23.

Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry.

Tan Z, Yin H, Nie S, Lin Z, Zhu J, Ruffin MT, Anderson MA, Simeone DM, Lubman DM.

J Proteome Res. 2015 Apr 3;14(4):1968-78. doi: 10.1021/acs.jproteome.5b00068. Epub 2015 Mar 9.

24.

Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial.

Azrad M, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT 4th, Moul JW, Brenner D, He X, Demark-Wahnefried W.

Biotech Histochem. 2015 Apr;90(3):184-9. doi: 10.3109/10520295.2014.976840. Epub 2014 Dec 1.

25.

Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.

Nie S, Yin H, Tan Z, Anderson MA, Ruffin MT, Simeone DM, Lubman DM.

J Proteome Res. 2014 Dec 5;13(12):6058-66. doi: 10.1021/pr500934u. Epub 2014 Nov 24.

26.

Effects of vitamin E from supplements and diet on colonic α- and γ-tocopherol concentrations in persons at increased colon cancer risk.

Li Y, Sen A, Ren J, Askew LM, Sidahmed E, Brenner DE, Ruffin MT 4th, Turgeon DK, Djuric Z.

Nutr Cancer. 2015;67(1):73-81. doi: 10.1080/01635581.2015.965333. Epub 2014 Nov 5.

27.

Communication preference moderates the effect of a tailored intervention to increase colorectal cancer screening among African Americans.

Resnicow K, Zhou Y, Hawley S, Jimbo M, Ruffin MT, Davis RE, Shires D, Lafata JE.

Patient Educ Couns. 2014 Dec;97(3):370-5. doi: 10.1016/j.pec.2014.08.013. Epub 2014 Sep 3.

PMID:
25224317
28.

The human gut microbiome as a screening tool for colorectal cancer.

Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD.

Cancer Prev Res (Phila). 2014 Nov;7(11):1112-21. doi: 10.1158/1940-6207.CAPR-14-0129. Epub 2014 Aug 7.

29.

Screening and prevention in primary care. Preface.

Ruffin MT 4th, Shultz CG.

Prim Care. 2014 Jun;41(2):xvii-xviii. doi: 10.1016/j.pop.2014.02.013. Epub 2014 Feb 28. No abstract available.

PMID:
24830617
30.

Screening strategies for colorectal cancer in asymptomatic adults.

Turgeon DK, Ruffin MT 4th.

Prim Care. 2014 Jun;41(2):331-53. doi: 10.1016/j.pop.2014.02.008. Epub 2014 Mar 26. Review.

PMID:
24830611
31.

Diagnosis and management of pancreatic cancer.

De La Cruz MS, Young AP, Ruffin MT.

Am Fam Physician. 2014 Apr 15;89(8):626-32.

32.

Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer.

Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE.

Mol Carcinog. 2015 Sep;54(9):908-15. doi: 10.1002/mc.22163. Epub 2014 Apr 24.

33.

Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis.

Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT, Lubman DM.

J Proteome Res. 2014 Apr 4;13(4):1873-84. doi: 10.1021/pr400967x. Epub 2014 Mar 10.

34.

Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.

Katz ML, Oldach BR, Goodwin J, Reiter PL, Ruffin MT 4th, Paskett ED.

J Cancer Educ. 2014 Jun;29(2):318-24. doi: 10.1007/s13187-013-0604-8.

36.

Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS.

Lin Z, Yin H, Lo A, Ruffin MT, Anderson MA, Simeone DM, Lubman DM.

Electrophoresis. 2014 Aug;35(15):2108-15. doi: 10.1002/elps.201300376. Epub 2013 Dec 27.

37.

Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial.

Jimbo M, Kelly-Blake K, Sen A, Hawley ST, Ruffin MT 4th.

Trials. 2013 Nov 11;14:381. doi: 10.1186/1745-6215-14-381.

38.

Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians.

de la Cruz MS, Young AP, Ruffin MT 4th.

J Am Board Fam Med. 2013 Nov-Dec;26(6):720-7. doi: 10.3122/jabfm.2013.06.120260.

39.

Development of exchange lists for Mediterranean and Healthy Eating diets: implementation in an intervention trial.

Sidahmed E, Cornellier ML, Ren J, Askew LM, Li Y, Talaat N, Rapai MS, Ruffin MT, Turgeon DK, Brenner D, Sen A, Djuric Z.

J Hum Nutr Diet. 2014 Oct;27(5):413-25. doi: 10.1111/jhn.12158. Epub 2013 Sep 20.

40.

Serum metabolomic analysis of pancreatic cancer--letter.

Shakour S, Ruffin MT, Zick SM, Lubman DM, Nie S.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1921. doi: 10.1158/1055-9965.EPI-13-0672. No abstract available.

41.

HPV prevalence among women from Appalachia: results from the CARE project.

Reiter PL, Katz ML, Ruffin MT, Hade EM, DeGraffenreid CR, Patel DA, Paskett ED, Unger ER.

PLoS One. 2013 Aug 30;8(8):e74276. doi: 10.1371/journal.pone.0074276. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/7a4cfd0a-cf77-430e-89a0-b2576268e2eb.

42.

Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry.

Nie S, Lo A, Zhu J, Wu J, Ruffin MT, Lubman DM.

Anal Chem. 2013 Jun 4;85(11):5353-7. doi: 10.1021/ac400838s. Epub 2013 May 17.

43.

Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial.

Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z.

Cancer Prev Res (Phila). 2013 Jun;6(6):558-65. doi: 10.1158/1940-6207.CAPR-13-0019. Epub 2013 Apr 16.

44.

Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer.

Azrad M, Vollmer RT, Madden J, Dewhirst M, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner DE, Demark-Wahnefried W.

J Med Food. 2013 Apr;16(4):357-60. doi: 10.1089/jmf.2012.0159.

45.

What is lacking in current decision aids on cancer screening?

Jimbo M, Rana GK, Hawley S, Holmes-Rovner M, Kelly-Blake K, Nease DE Jr, Ruffin MT 4th.

CA Cancer J Clin. 2013 May;63(3):193-214. doi: 10.3322/caac.21180. Epub 2013 Mar 15. Review.

46.

Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial.

Citronberg J, Bostick R, Ahearn T, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM.

Cancer Prev Res (Phila). 2013 Apr;6(4):271-81. doi: 10.1158/1940-6207.CAPR-12-0327. Epub 2013 Jan 9.

47.

Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.

Azrad M, Zhang K, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner D, Hardy RW, Demark-Wahnefried W.

PLoS One. 2012;7(12):e53104. doi: 10.1371/journal.pone.0053104. Epub 2012 Dec 28.

48.

Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer.

Jiang Y, Turgeon DK, Wright BD, Sidahmed E, Ruffin MT, Brenner DE, Sen A, Zick SM.

Eur J Cancer Prev. 2013 Sep;22(5):455-60. doi: 10.1097/CEJ.0b013e32835c829b.

49.

An N-glycosylation Analysis of Human Alpha-2-Macroglobulin Using an Integrated Approach.

Lin Z, Lo A, Simeone DM, Ruffin MT, Lubman DM.

J Proteomics Bioinform. 2012 May 31;5:127-134.

50.

Family history assessment: impact on disease risk perceptions.

Wang C, Sen A, Ruffin MT 4th, Nease DE Jr, Gramling R, Acheson LS, O'Neill SM, Rubinstein WS; Family Healthware™ Impact Trial (FHITr) Group.

Am J Prev Med. 2012 Oct;43(4):392-8.

Supplemental Content

Loading ...
Support Center